Evolus, Inc.
A performance beauty company developing neurotoxins and dermal fillers.
EOLS | US
Overview
Corporate Details
- ISIN(s):
- US30052C1071
- LEI:
- Country:
- United States of America
- Address:
- 520 NEWPORT CENTER DRIVE, 92660 NEWPORT BEACH
- Website:
- https://www.evolus.com/
- Sector:
- Manufacturing
Description
Evolus, Inc. is a performance beauty company focused on the medical aesthetics market. The company develops and commercializes a portfolio of aesthetic products for the cash-pay sector, targeting both healthcare practitioners and consumers. Its flagship product is Jeuveau® (prabotulinumtoxinA-xvfs), a neurotoxin used for the temporary improvement of moderate to severe glabellar lines in adults. Evolus is expanding its offerings with the Evolysse™ line of hyaluronic acid-based dermal fillers, designed to correct facial wrinkles and folds. The company supports its customer-centric approach with consumer engagement platforms, including the Evolus Rewards loyalty program and the Club Evolus subscription service.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Evolus, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evolus, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evolus, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
